Depression Research and Treatment (Jan 2021)

Depressive and Anxiety Symptom Assessment in Adults with Polycystic Ovarian Syndrome

  • Wadha K. Almeshari,
  • Alanoud K. Alsubaie,
  • Reham I. Alanazi,
  • Yara A. Almalki,
  • Nazish Masud,
  • Sami H. Mahmoud

DOI
https://doi.org/10.1155/2021/6652133
Journal volume & issue
Vol. 2021

Abstract

Read online

Background. Polycystic ovarian syndrome (PCOS) is an endocrinopathic disorder commonly affecting women in the reproductive age. These women have a possibility of developing depression and anxiety due to biochemical changes, concerns regarding physical appearance, and social pressure from infertility. Thus, the connection between PCOS, anxiety, and depression has a possible impact on patients’ quality of life. This study is aimed at assessing depression and anxiety symptoms among PCOS patients and their association with different socioeconomic aspects. Methods. A cross-sectional study was conducted to assess depression and anxiety symptoms on 250 PCOS patients which were selected through consecutive sampling technique. Arabic versions of the HAM-A and HAM-D questionnaires were used alongside a demographic sheet to determine the socioeconomic and fertility status. Results. Prevalence of anxiety symptoms was reported among 100 (40%) of women and was found to be significantly higher in single women with a prevalence of 59 (48%) (χ2=5.8, p value <0.01). Also, lower-income status and unemployment were associated with a significantly higher prevalence of anxiety 18 (67%) (χ2=10.3, p value =0.03) and 71 (45%) (χ2=4.5, p value =0.03) women, respectively. Depressive symptoms were reported among 122 (49%) participants. Conclusion. Single marital status, low income, and unemployment were predictors of anxiety. Tension was noted to be the most common anxiety symptom among participants while depressed mood and psychological anxiety were the most reported depressive symptoms. It is important to note the link between anxiety, PCOS, and depression when deciding treatment plans for affected women.